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ABSTRACT 
Home and outpatient parenteral antibiotic therapy offers poten- 
tial cost savings as well as improved quality of care in many 
countries. This form of therapy has been successful in coun- 
tries with adequate resources for health care, but the poten- 
tial benefits in other countries should also be considered. 
Parenteral therapy can be provided by a visiting nurse, at an 
infusion center, or through self-administration models, depend- 
ing upon patient need, resources available, and the experience 
of the medical team. There are, however, a number of factors 
to consider in establishing or developing an outpatient infusion 
therapy program. A dedicated team of health care workers 
with knowledge of parenteral therapy and with access to med- 
ications and devices for vascular access and infusion is essen- 
tial. Other considerations include the local geography, home 
environment, knowledge of medicine, and cultural attitudes. 
Financial and political problems are often limiting factors. The 
concepts involved in managed care continue to expand out- 
patient and home therapy in the United States and will likely 
bring change to other countries as well. 
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The use of intravenous (IV) antibiotics for the treatment 
of serious infections has become commonplace around 
the world. It is accepted as the standard of therapy for 
many infections, including sepsis, meningitis, endo- 
carditis, intra-abdominal infections, pneumonia, and 
osteomyelitis. Intravenous antibiotics have traditionally 
been given in the hospital, but increasingly they are given 
at home or in a clinic or physician’s office. 
Over the past decade, in the United States, the cost 
of medical care has progressively increased to over one 
trillion dollars per year, or more than 12% of the Gross 
National Product. There has been increasing concern 
about these health care costs and the willingness of the 
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citizenry and employers to pay for it. In response to the 
spiraling costs, “managed care” has emerged with 
restrictive measures and changes in incentives to reduce 
costs through limiting the use of resources. The impact 
of managed care on the quality of care has yet to be 
adequately assessed. 
One of the few areas of medicine that offers the 
potential to save money as well as improve the quality of 
patient care is that of home and outpatient IV antibiotic 
therapy (OPAT). With the cost of a day in the hospital in 
the United States at more than $1000, it is easy to con- 
struct outpatient IV therapy programs that can be far less 
expensive.‘-3 This form of treatment has expanded rapidly 
since it was first reported in 1974 and now accounts for 
more than a billion U.S. dollars in expenses annually4 It 
appears that it is not only a cost savings, but that it pro- 
vides an improved quality of life as well, with minimal, 
if any, compromise in outcomes5-’ 
Although the greatest use of OPAT has been in the 
United States, there have been pioneering efforts in 
Canada as well8 Recently, there has been an interest in 
outpatient therapy in many other countries as well, with 
reports of successful programs in Argentina,9 Australia,lO 
Canada,‘ls12 Israe1,13z14 Mexico,15 Norway,” The Nether- 
lands l7 and Venezuela.18 
Intravenous therapy outside the hospital, has only 
recently become possible, with the introduction of new 
antibiotics, better catheters for vascular access, and 
improved infusion devices. Health care professionals have 
pioneered the development of OPAT and worked 
together to develop safe and effective programs. The 
involvement of a team of health care workers, including 
a physician, nurse, and often a pharmacist and social 
worker is particularly important.19,20 Although cost savings 
have been the primary driving force in the rapid expan- 
sion of OPAT in the United States, there are other bene- 
fits as well, such as the ability of many persons to return 
to work or school while undergoing therapy, avoidance 
of the antibiotic-resistant organisms of the hospital, plus 
quality-of-life factors (e.g., sleep, privacy, clothing, and 
food quality). 
It is commonly agreed that hospitalization for IV 
antibiotic therapy is often not necessary, yet it remains 
a requirement in many countries. This article explores 
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the reasons for the variations in use of OPAT among dif- 
ferent countries and cultures. 
MODELS FOR DELIVERY 
The most common models for delivery of outpatient infu- 
sion therapy may be classified as (1) the visiting nurse 
model, (2) the infusion center model, and (3) the self- 
administration mode1.20 If a visiting nurse service is 
already established and well developed in a country, this 
model may work well to provide parenteral antibiotic 
therapy, especially if it needs to be given only once a 
day. The nurse simply visits the home and gives an intra- 
muscular injection or uses an intravenous line to infuse 
the antibiotic. This model offers the safety of supervised 
administration by a nurse and is a particular advantage for 
a patient who is confined to bed. It also offers the oppor- 
tunity to assess a patient in the home environment, which 
may be quite revealing. 21 It may not be useful, however, 
if the visiting nurses are not trained in intravenous ther- 
apies or if travel to the patient’s home is difficult because 
of long distances, traffic, or weather. The safety of a nurse 
visiting some neighborhoods must also be considered. 
Costs become a factor if multiple infusions per day are 
needed or home visits are costly (over $100 each in the 
United States). In some countries (i.e., Austria and Israel), 
the visiting nurse model for OPAT is impractical because 
nurses are not allowed to start intravenous lines. 
The infusion center model is an easy one to establish. 
Patients travel to the infusion center for therapy. In this 
model, the infusion center may be located in a hospital 
clinic, a doctor’s office,22 an emergency room,13 a nurs- 
ing home, or a free-standing infusion center.23 This model 
offers the advantages of ready access to professional staff 
as well as medical equipment, medications, and often 
laboratory and x-ray facilities as well. The center may 
also be used for other intravenous therapies, such as 
chemotherapy, blood transfusions, and fluid therapy. In 
this model it is convenient for the doctor to see patients. 
Again, the ability to use a once-a-day antibiotic is an 
advantage. The major limitation to the model is difficulty 
for the patient, and often the family, to travel to the facil- 
ity. In some countries, pharmacists may administer par- 
enteral medications in their stores, especially if there are 
no restrictions on medication use and ordering. An inter- 
esting variation is the use of a mobile van to travel to the 
patient to provide parenteral medication in the home or 
inside the van.18 
The model of self-administration has the advantage 
of avoiding even the once-a-day travel. Patients who are 
stable on IV antibiotic therapy usually need to be seen 
only once or twice a week by the physician if they can 
administer their own medications. Infusions are given by 
the patient or family member using a gravity drip sys- 
tem, or with an automatic system such as a battery- 
driven, computer-operated pump that can be easily 
carried around. Generally, patients can be trained to be 
efficient in self-administration and may do as good a job 
as hospital nurses can.8 This system allows the patient 
great freedom and reduces the expenses of an infusion 
center or nursing visits. It may be a problem, however, 
if the patient or family is not trained well or if there are 
questions about their reliability 
ADVANCES IN TECHNOLOGY 
A wide variety of technology is now available for home 
and outpatient therapy. 25 The classic steel needles and 
short plastic cannulas remain useful but have their limi- 
tations in prolonged therapy, especially if the therapeu- 
tic agents cause phlebitis. There is now an assortment of 
Silastic and polyurethane catheter lines available that can 
be placed into a large central vein and used for months 
or even years. These consist of lines that are inserted 
directly into the subclavian vein under the clavicle then 
tunneled under the skin to an exit site on the anterior 
chest. In Mexico City, these have proven particularly suc- 
cessful in providing chemotherapy, when supervised by 
a well-trained IV nursing staff.15 Another variation is the 
subcutaneous port, which is positioned beneath the skin 
and can be accessed with a special angled needle. 
Recently, there has been great interest in central venous 
access through peripherally inserted central catheter 
(PICC) lines. These are usually inserted in an antecubital 
vein then threaded to the superior vena cava with the 
help of a guidewire, which is easily removed. These PICC 
lines can be placed by a nurse and appear to be remark- 
ably safe and long lasting. 26~27 The Silastic or polyurethane 
catheters come in sizes varying from 3 to 5 French and 
can be passed through 20- to 16-gauge needles. 
New infusion devices have been developed that 
range from elastomeric and even osmotic pumps to 
advanced computer technology (Figure 1). The elas- 
tomeric pumps have a balloon within a plastic bulb that 
can be filled with medications and stored for infusion 
later. Pressure for infusion is generated by the balloon 
inside. Battery-driven, computer-operated pumps are able 
to administer medications at virtually any intervals or 
rates needed. Some pumps can run for days at a time. 
Some have computers that can be re-programmed over 
the telephone to change dosing. With these new pumps, 
reliability of drug administration can be as good as, if not 
better than in the hospital, and with minimal nursing or 
other staff time. 
ENVIRONMENTAL FACTORS 
Geographic factors may play a major role in the poten- 
tial application of outpatient parenteral therapies. If there 
is a sparse population with poor travel routes or a 
rugged, mountainous terrain, outpatient therapy may not 
be feasible. Weather may also play a significant role, 
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Figure 1. Infusion devices that can be used for intravenous anti- 
biotic administration. A, The elastomeric device works like a balloon that 
is filled with fluid then can be stored for use in infusing antibiotic. B, 
The syringe pump makes controlled administration possible with the 
use of the mixing syringe. C, The computerized pump can be pro- 
grammed to administer antibiotics at any interval from once daily to con- 
tinuous infusion. 
particularly during the winter or monsoon seasons. Traf- 
fic may be a major obstacle in some large cities where it 
may take 2 hours to cross town. Outpatient therapy is 
usually not practical unless the travel time to a medical 
facility is less than an hour. 
The home environment should also be considered. 
Many homes do not have the facilities for cleaning or the 
level of sanitation available in a hospital. It may be far 
safer and more reasonable to keep a person in the hos- 
pital if the home situation is unclean or unsafe or with- 
out running water or sanitation. Access to a telephone 
and emergency transportation are additional important 
factors. An inadequate home environment may result in 
a slow recovery or recurrence of the disease that is being 
treated. In many situations, a patient may be better off in 
the hospital from simply a nutrition or safety standpoint. 
There are additional considerations in regard to 
safety. Some patients should stay in the hospital if they 
live in a high crime neighborhood or have to deal with 
warfare or curfews that prevent access to emergency care 
or needed medications. The safety of the health care 
worker must also be considered. It may not be appro- 
priate to have a nurse visit a home in a high crime or 
unsafe neighborhood, particularly after dark. 
LEVEL OF HEALTH CARE KNOWLEDGE 
The basic level of health care knowledge of a population 
should also be considered in regard to the potential value 
C 
of outpatient therapy In some countries the knowledge 
of medicine and disease may be rudimentary with few 
medical services and no available hospitals. In other coun- 
tries, there may be a well-established visiting nurse ser- 
vice that easily can be utilized to provide community 
care in lieu of hospitalization. With outpatient therapy, 
the patient and family play an important role and must 
have some basic knowledge of anatomy, physiology, med- 
icine, and disease. An understanding of aseptic technique 
is essential when considering outpatient therapy. A few 
days in the hospital may also provide an opportunity for 
intensive education and training. If there is a reasonable 
knowledge of health care by the people being served 
and adequate resources to provide outpatient care, OPAT 
should be possible. 
The delivery model used for OPAT will vary accord- 
ing to the development or sophistication of the country 
in regard to health care and the resources available. If a vis- 
iting nurse service is well developed, nurses easily can be 
used to provide intramuscular or intravenous medication. 
For countries in which the medical care system is cen- 
tered in hospitals, outpatient infusion units may be suc- 
cessful with patients coming to a hospital infusion center 
on a daily basis. For countries with greater resources to 
devote to health care, the selfadministration technique 
may be useful, because although it can save staff and over- 
head expenses, it does require some investment in vascu- 
lar access and infusion devices as well as well-trained 
medical personnel to evaluate, treat, and monitor patients 
who traditionally have been treated in the hospital. 
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CULTURAL ISSUES 
Patients and their families should have a basic knowledge 
of health care to allow safe, effective outpatient therapy. 
It is also important that they have a positive attitude 
toward this and be willing and able to learn about out- 
patient therapy.28 Some patients and their families expect 
the services of a hospital when they are sick and may be 
offended by the suggestion that they provide more care 
for themselves. Selection of the right patients is critical 
to the success of an outpatient program.’ Outside the 
hospital, the patient becomes an integral part of the 
health care team and must play a greater role in the eval- 
uation and treatment of his or her own disease. Knowl- 
edge of the disease, its symptoms, and the possible 
adverse effects of the medication are important, as there 
is little monitoring between visits by the nurse or to the 
clinic. Patients must be able to take some responsibility 
for their course of treatment and should be able to alert 
their nurse or physician promptly about new symptoms 
or any problems that arise. For example, it may be diffi- 
cult for patients to understand why it is necessary to con- 
tinue OPAT once they start to feel better. They need to 
know that their infection may relapse if they do not com- 
plete the course of therapy. 
In some cultures there may be a fear of modern tech- 
nology, which may preclude use of some of the more 
sophisticated devices. In other countries there may be a 
preference for parenteral medications, as with intramus- 
cular injections in Italy. Generally, intravenous therapy is 
well accepted and even looked to as testimony of the 
seriousness of one’s illness and, hence, the need for sym- 
pathy or respect. 
It should also be recognized that hospitals play an 
important social role in many cultures. If a person is hos- 
pitalized, the family is usually obligated to visit and pay 
respect to the ill individual. Illness may be an important 
event in many people’s lives, indicating a need for a 
change in lifestyle or bringing knowledge of a poor prog- 
nosis. A period of hospitalization may allow the individ- 
ual to adjust to the new circumstances of their life, which 
may be more difficult at home. It may also be a time of 
honor and respect. Patients do not get that respect if 
they are treated at home with intravenous therapy or 
told they can go back to work with a portable pump. 
Hospitalization also allows escape from the rigors of work 
or school-which may be good or bad. 
outpatient clinics when medication is available. Most 
countries have a system of public and private hospitals 
for care and provide IV antibiotics through these facili- 
ties. Even in developing countries, however, there is often 
a wealthy elite who prefer to be treated at home and can 
easily pay privately for medical care, antimicrobials, and 
technology, if they are available. When economies 
progress to where people can purchase health insurance, 
there are incentives for outpatient care, depending upon 
the cost of hospitalization. 
In some countries, hospital care costs may be low 
and, hence, incentives for outpatient care are small. The 
cost of outpatient care also may vary depending upon 
the model used and the price of the visiting nurse ser- 
vices or outpatient facilities. The least expensive model 
is usually that of the infusion center, although the most 
sophisticated self-administration systems may be less 
expensive in advanced medical environments. 
The potential economic impact of outpatient ther- 
apy on the health care worker should also be considered. 
Nurses may make more or less money in outpatient care 
than in the hospital, depending on the reimbursement 
systems. They probably also feel that their job may be 
threatened if they train patients in self-administration. 
Physicians generally make less money with outpatient 
care in a fee-for-service system, because the patient may 
be seen only a few times a week, whereas in the hospi- 
tal the patient may be seen by two or three different 
physicians each day. In a capitated system or when the 
doctors are on salary, their income may stay the same 
even though their work is less with outpatient care. 
In many areas, hospitals are the focus of health care, 
and their income is dependent upon keeping their beds 
filled. If a hospital is not operating at or above capacity, 
then outpatient care threatens bed occupancy. In this sit- 
uation, hospital administrators and staff may be reluctant 
to encourage or allow OPAT. 
There are also problems with allocation of finances 
in public health care. In the British system there are usu- 
ally separate budgets for hospital, physician, and visiting 
nurse care. Outpatient parenteral therapy overlaps all 
three of these areas, but neither the physicians, nurses, 
nor hospital administrators want to contribute toward it. 
In Canada, some of the provincial governments have 
funded independent studies of OPAT programs, particu- 
larly for HIV-infected patients. 
Another problem may be access to medications and 
technology. When money is available for medications and 
equipment, there may still be problems getting them, 
because of customs, taxation, government approval, or 
an absent sales or distribution system. 
Managed care in the United States will be a tremen- 
dous force in encouraging home and outpatient therapy. 
The incentive is obviously to reduce costs of care. If a for- 
profit organization can save $500 or more per patient 
per day, it will aggressively try to do so and pass the 
FINANCIAL AND POLITICAL CONSIDERATIONS 
Virtually all countries other than the United States have 
a universal health care system. However, their ability to 
provide medical care to the populace varies tremen- 
dously. Some countries do not have the finances to build 
hospitals so their primary form of therapy is through 
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savings on to shareholders. It is not clear what the safety 
limits are to OPAT. It will be important to define them. 
CONCLUSION 
Advances in antibiotic development and intravenous ther- 
apy technology, and the interest of the medical profes- 
sions have made OPAT practical in most countries. 
Outpatient parenteral therapies offer the potential for 
cost savings as well as improving quality of patient care. 
To determine the most appropriate model of delivery of 
outpatient parenteral therapy and to assemble the appro- 
priate people to provide it, organizers must overcome 
multiple potential obstacles, in terms of basic knowledge 
of health care, access to medicines and technology, envi- 
ronmental factors, cultural issues, and of course, financial 
and political constraints. All of these factors must be con- 
sidered to develop an understanding of the potential 
value in establishing an OPAT program in various com- 
munities or countries. The influence of managed care 
will likely grow and stimulate outpatient therapy in the 
United States and, potentially, in other countries as well. 
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